What is the diagnosis and appropriate management for a patient with serum iron 20 µg/dL, transferrin saturation 5 %, and ferritin 5 ng/mL?

Diagnosis: Severe Iron Deficiency Anemia

This patient has severe iron deficiency anemia requiring immediate iron replacement therapy, with oral iron as first-line treatment unless contraindications exist, and mandatory investigation for the underlying cause of blood loss.

Laboratory Interpretation

Your patient's values demonstrate profound iron deficiency:

• Serum iron 20 µg/dL (normal: 60-170 µg/dL) - severely depleted
• Transferrin saturation 5% (normal: 20-50%) - critically low, indicating insufficient iron available for erythropoiesis
• Ferritin 5 ng/mL (normal: 30-300 ng/mL) - severely depleted iron stores

These values unequivocally confirm absolute iron deficiency 1, 2. The ferritin of 5 ng/mL is far below any diagnostic threshold (the AGA recommends <45 ng/mL as diagnostic) 1, and the transferrin saturation of 5% is critically low (diagnostic threshold is <20%) 3, 2.

Immediate Management Algorithm

Step 1: Initiate Iron Replacement

Start oral iron supplementation immediately 1, 2:

• Ferrous sulfate 325 mg (65 mg elemental iron) every other day on an empty stomach
• Every-other-day dosing improves absorption and reduces gastrointestinal side effects compared to daily dosing 2
• If not tolerated on empty stomach, take with meals (preferably with meat protein and 500 mg vitamin C to enhance absorption) 1
• Alternative formulations (ferrous fumarate, ferrous gluconate, ferrous bisglycinate) if ferrous sulfate not tolerated 1

Consider intravenous iron if 1, 2:

• Oral iron not tolerated (occurs in ~50% of patients) 2
• No response after 2-4 weeks of oral therapy
• Patient has chronic heart failure (IV iron improves exercise capacity and outcomes) 3, 4
• Severe anemia requiring rapid repletion
• Malabsorption suspected

Step 2: Investigate the Underlying Cause

This is mandatory - iron deficiency this severe indicates ongoing blood loss in 94% of cases 2.

For premenopausal women:

• Assess menstrual blood loss patterns
• If heavy menstrual bleeding is clearly present and patient is young, reasonable to treat bleeding source and provide iron supplementation initially 2
• However, still perform non-invasive testing for H. pylori and celiac disease 1
• If no response to treatment or concerning features, proceed to endoscopy

For men and postmenopausal women:

• Bidirectional endoscopy (upper and lower GI) is mandatory 2
• Non-invasive testing for H. pylori infection 1
• Celiac disease serologies 1
• Consider small bowel evaluation if upper and lower endoscopy unrevealing

For all patients, evaluate:

• Dietary iron intake assessment
• Medications (NSAIDs, anticoagulants, antiplatelet agents)
• Chronic kidney disease (check creatinine/GFR)
• Inflammatory bowel disease symptoms
• Chronic heart failure symptoms

Step 3: Monitor Response

Reassess in 2-4 weeks 2:

• Check hemoglobin, ferritin, and transferrin saturation
• Expected response: hemoglobin increase of 1-2 g/dL over 3-4 weeks with oral iron
• If inadequate response, switch to intravenous iron 2

Treatment targets:

• Hemoglobin normalization (>12 g/dL in women, >13 g/dL in men)
• Ferritin >100 µg/L 5
• Transferrin saturation >20% 5

Critical Pitfalls to Avoid

1. Do not delay investigation: With ferritin this low, there is an underlying cause that must be identified - most commonly GI blood loss 2

2. Do not assume dietary insufficiency alone: While dietary assessment is important, ferritin of 5 ng/mL typically indicates chronic blood loss, not just poor intake 1

3. Do not use daily oral iron dosing: Every-other-day dosing improves absorption and tolerability 2

4. Do not overlook celiac disease and H. pylori: Both are common, treatable causes of iron deficiency anemia 1

5. Do not continue oral iron indefinitely without response: If no improvement in 2-4 weeks, switch to IV iron 2

Special Considerations

If inflammatory conditions present (IBD, CKD, CHF): The diagnostic thresholds differ, but your patient's values are so profoundly low that they indicate absolute iron deficiency regardless of inflammation 3, 6. However, IV iron may be preferred in these conditions due to impaired oral absorption 3.

Transferrin saturation is the key prognostic marker: Recent evidence shows TSAT <20% (not ferritin) predicts outcomes and treatment response, particularly in heart failure 4, 7. Your patient's TSAT of 5% indicates severe functional impairment of iron availability for erythropoiesis.